Farci, P. Et Al. 2005. On-treatment predictors of sustained biochemical and virological response in patients with HBeAg-negative chronic hepatitis B (CHB) treated with peginterferon alpha-2a (40 kDa) (Pegasys (R)). 40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver , (Paris, France), 175.

Farci, P., Marcellin, P., Lu, Z., Diago, M., Lai, M., Gurel, S., ... Kittis, G.(2005). On-treatment predictors of sustained biochemical and virological response in patients with HBeAg-negative chronic hepatitis B (CHB) treated with peginterferon alpha-2a (40 kDa) (Pegasys (R)) . 40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (pp.175). Paris, France

Farci, P Et Al. "On-treatment predictors of sustained biochemical and virological response in patients with HBeAg-negative chronic hepatitis B (CHB) treated with peginterferon alpha-2a (40 kDa) (Pegasys (R))," 40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Paris, France, 2005

Farci, P Et Al. "On-treatment predictors of sustained biochemical and virological response in patients with HBeAg-negative chronic hepatitis B (CHB) treated with peginterferon alpha-2a (40 kDa) (Pegasys (R))." 40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver , Paris, France, pp.175, 2005

Farci, P. Et Al. (2005) . "On-treatment predictors of sustained biochemical and virological response in patients with HBeAg-negative chronic hepatitis B (CHB) treated with peginterferon alpha-2a (40 kDa) (Pegasys (R))." 40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver , Paris, France, p.175.

@conferencepaper{conferencepaper, author={P Farci Et Al. }, title={On-treatment predictors of sustained biochemical and virological response in patients with HBeAg-negative chronic hepatitis B (CHB) treated with peginterferon alpha-2a (40 kDa) (Pegasys (R))}, congress name={40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver}, city={Paris}, country={France}, year={2005}, pages={175} }